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The FceRIb Subunit Functions as an Amplifier
of FceRIg-Mediated Cell Activation Signals
Siqi Lin, Claudia Cicala, Andrew M. Scharenberg, particular individual to an allergen is more intense than
that of another are poorly understood. However, theand Jean-Pierre Kinet
importance of genetic background in the developmentLaboratory of Allergy and Immunology
of atopic disease is underscored by the tendency ofDepartment of Pathology
severe atopic disease to run in families. Recently, sev-Beth Israel Hospital
eral studies have reported associations of atopic dis-Harvard Medical School
ease with molecules involved in the IgE/FceRI signaling99 Brookline Avenue
pathway, most notably correlation of serum IgE levelsBoston, Massachusetts 02215
with the severity or occurrence of asthma (Martinez et
al., 1994; Parks et al., 1990; Tollerud et al., 1991), genetic
linkage between serum IgE levels and a large cytokineSummary
locus that includes IL-4 (Meyers et al., 1991, 1994), and
association of polymorphisms of the FceRIb chain (anThe high affinity IgE receptor (FceRI) plays a central
FceRI subunit) gene with the development of an atopicrole in the initiation of allergic responses. FceRI is
phenotype (Cookson et al., 1989; Sandford et al., 1993;multimeric and is expressed as either ag2 trimers or
Shirakawa et al., 1994). Taken together, these studiesabg2 tetramers. Recently, polymorphisms of the b
suggest that perturbations in IgE/FceRI-mediated cellchain gene have been associated with the develop-
activation can contribute to the initiation or maintenancement of various allergic phenotypes. Until now, the
of atopic diseases and that, at least in some individuals,role of b in FceRI-dependent signaling was largely
the b chain may be a component of such a perturbation.unknown. For that reason, we compared the signaling
Understanding how atopy-associated FceRIb poly-characteristics of various wild-type and mutant ag2
morphisms might affect the in vivo response of an indi-and abg2 FceRI complexes. These studies demon-
vidual to allergens is complicated by the existence ofstrate that the g dimer functions as an autonomous
two distinct types of FceRI complexes in humans. Basedactivation module, while b functions as an amplifier
on analyses demonstrating that surface expression ofthat provides a gain of 5- to 7-fold, as measured by
rodent a occurs only when b and g are bothalso present,Syk activation and calcium mobilization.
FceRI was originally thought to exist as a tetramer of
one a subunit, one b subunit, and one disulfide-linked
Introduction g subunit dimer (abg2) (Blank et al., 1989). However, the
human a subunit was later found to express as an ag2
The prevailing view of the pathophysiology of atopic complex in transfectants (Miller et al., 1989), and ag2
disease (reviewed by de Vries et al., 1991; Geha, 1992) complexes were subsequently shown to exist naturally
presumes that B cells of atopic patients produce immu- in humans on cells such as monocytes, which lack b
noglobulin E (IgE) directed against specific antigens (al- chain expression (Maurer et al., 1994). The ability of
lergens), a process under the control of interleukin-4 human a to express in ag2 complexes has the additional
(IL-4). Once produced, allergen-specific IgE binds implication that ag2 and abg2 complexes may both be
through its Fc portion to the high affinity IgE receptor expressed on cells that do express b. Since the relative
(FceRI) present on mast cells, basophils, and various proportion of these complexes may vary between indi-
other cells (Gounni et al., 1994; Maurer et al., 1994; viduals, how an individual responds to an immunologic
Wang et al., 1992). Contact between these cells and the reaction mediated by FceRI may depend on the relative
corresponding allergen induces the clustering of FceRI, signaling capabilities of ag2 and abg2 receptors. While
a step required to induce cell activation. In the case of current literature suggests that ag2 and abg2 receptors
mast cells and basophils, the activation process results both have the ability to activate hematopoietic cells
in the release of histamine, leukotrienes, and other sub- (Alber et al., 1991), their relative capabilities have not
stances that contribute to the characteristic symptoms been characterized in detail.
of type I allergic reactions such as pruritis, edema, in- An understanding of the function of the FceRIb chain
creased mucus production, and bronchoconstriction. In is an obvious prerequisite for any analysis of how FceRIb
addition, these cells produce an array of proinflamma- polymorphisms might contribute to the development of
tory cytokines, resulting in the recruitment and activa- atopic disease. FceRIb is unique among known antigen
tion of circulating leukocytes to the area of the initial receptor subunits in that it spans the plasma membrane
reaction, and in an enhancement of the initial inflamma- four times and, therefore, has both amino-terminal and
tory response (Galli, 1993; Gordon and Galli, 1991). carboxy-terminal tails protruding into the cytoplasm
Therefore, FceRI is a critical component of the effector (Kuster et al., 1992). The amino-terminal tail is notable
armof theallergic response, and may additionallypartic- for containing a number of proline residues but has no
ipate in the maintenance of allergen-specific IgE pro- ascribed function. The carboxy-terminal tail contains a
duction by providing positive feedback in the form of sequence similar to those that have been implicated in
mast cell– or basophil-generated cytokines such as antigen receptor–mediated cell activation and has been
IL-4 (Burd et al., 1989; Gauchat et al., 1993; Plaut et al., designated the immunoreceptor tyrosine-based activa-
1989; Schroeder et al., 1994). tor motif (ITAM) (Cambier, 1995; Reth, 1989). However,
the FceRIb ITAM has a slightly shorter spacing betweenThe factors that determine why the response of a
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hematopoietic cell line. We therefore performed func-Table 1. Receptor Variants Expressed by Transfected NIH 3T3
Cells tional comparisons of ag2 and abg2 receptors in the U937
monocytic cell line. The g tyrosine phosphorylation andSubline
Syk tyrosine kinase activation mediated by ag2 and abg2Name cDNAs Used in the Transfection
receptors inU937 cellswere similar in relative magnitude
abg2 Wild-type a, b and g to those determined in the reconstitution system, and
ag2 Wild-type a and g
the gain in Syk activation provided by the presence ofagYM2 Wild-type a, and mutated g with 2 tyrosines changed
b was nearly identical in both systems. In addition, theto phenylalanines within the ITAM
abgYM2 Wild-type a and b, and mutated g with 2 tyrosines amplified Syk tyrosine kinase activation translated into
changed to phenylalanines within the ITAM an amplification of the magnitude of the population cal-
abYMg2 Wild-type a and g, and mutated b wtih 3 tyrosines cium flux. The results from these experiments show that
changed to phenylalanines within the ITAM
abg2 receptors transduce substantially stronger cell ac-abYMgYM2 Wild-type a, and tyrosine-mutated b and g
tivation signals than ag2 receptors. Because ag2 andabNTg2 Wild-type a and g, and NH2-terminal truncated form of
abg2 receptors exist naturally in humans, these resultsb (bNT, first 57 amino acids of NH2-terminal cytoplasmic
domain deleted) have important implications for understanding how
abCTg2 Wild-type a and g, and COOH-terminal truncated form atopy-associated b gene polymorphisms might partici-
of b (bCT, last 38 amino acids of COOH-terminal cyto- pate in the pathogenesis of atopic disease.
plasmic domain deleted)
Results
the two critical tyrosine residues (6 residues as opposed
to7 residues in the motif consensus).FceRIg has a single Comparison of ag2 and abg2 Receptors
in a Reconstitution System: the Conceptmembrane-spanning domain and exists as a disulfide-
linked dimer within the multimeric holoreceptor (Letour- of b as a Signal Amplifier
For our initial functional comparisons of the signalingneur et al., 1991). Its carboxy terminus contains an ITAM
that conforms exactly to the ITAM consensus. The pres- characteristics of ag2 and abg2 receptors, we chose a
reconstitution system that has been established in ourence of ITAMs in both b and g suggests that they both
participate in signals transduced through tetrameric laboratory (Scharenberg et al., 1995). This system is
based on clones derived from the nonhematopoietic NIHFceRI complexes. Current data on ITAM function sug-
gest that multiple motifs function additively to increase 3T3 cell line by transfection with FceRI subunits so as
to express various FceRI surface complexes. FceRI-spe-thestrength of a particular signal, or separately to gener-
ate parallel signals (Weiss, 1993; Weiss and Littman, cific cytoplasmic signaling molecules are added back
through infection with recombinant vaccinia viruses. The1994). Previous results from our laboratory and others
have demonstrated that the b and g ITAMs differentially use of this system allows us to control the presence
and molecular structure of each receptor componentinteract with the Lyn and Syk tyrosine kinases, respec-
tively, and have different functional characteristics in and the Lyn and Syk tyrosine kinases in the experiments
below. In addition to providing complete and flexiblethe context of single-chain chimeric receptors, consis-
tent with the idea that they have different signaling func- control over each experimental variable, the use of this
system allows the b and g subunit tyrosine phosphoryla-tions (Jouvin et al., 1994; Kihara and Siraganian, 1994).
However, the reported ability of ag2 receptors to activate tion in the experiments described below to be unambig-
uously attributed to Lyn and avoids potentially con-cells normally suggests that b is dispensable for at least
some aspects of FceRI-mediated signaling (Alber et al., founding influences of other surface Fc receptors or
hematopoietic regulatory molecules.1991). Therefore, the signaling properties of b appear
to be distinct from those of g, but whether and, if so, Lyn-Dependent Phosphorylation of g Is Much
Greater in abg2 Complexes thanhow these properties translate into a unique function
for b in the generation or downstream propagation of in ag2 Complexes
As a first step in comparing the signaling characteristicsFceRI-mediated signals is currently unknown.
To understand better the role of b in the generation of ag2 and abg2 receptors, we generated NIH 3T3 cell
lines expressing either ag2 or abg2 FceRI (Table 1). Sur-of FceRI-mediated signals, we performed a detailed
comparison of the signaling capacity of abg2 and ag2 face expression of FceRI on selected clones was ana-
lyzed by flow cytometry (Figure 1A, top two panels).complexes and of a variety of FceRI mutants, using a
previously described reconstitution system (Scharen- Relative levels of surface receptor expression of the
abg2 and ag2 cell lines were further evaluated by an IgEberg et al., 1995). The results from this approach demon-
strate that b functions as an amplifier of g-mediated binding assay (3.0 3 105 receptors/cell for abg2, and
2.1 3 105 for ag2). These data show that both cell linesactivation of the Syk tyrosine kinase. Molecular analysis
of the b amplification mechanism suggests that it in- have surface receptor expression comparable to that
seen in cultured mast cell lines used to study IgE recep-volves both b cytoplasmic tails and that it is mediated
through a distinct sequence of interactions between b tor signaling.
We used these cell lines to compare directly the capa-and Lyn. The ability of b to amplify Syk activation trans-
duced through g suggested that human ag2 and abg2 bility of ag2 and abg2 complexes to induce Lyn-depen-
dent phosphorylation of g upon receptor clustering withreceptors would have substantially different signaling
characteristics in terms of their abilities to activate antigen (Figure 1B). In this experiment, the abg2 and ag2
NIH 3T3 cell lines were first incubated with IgE. Since thedownstream effectors when placed in the context of a
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ag2 cells have approximately two-thirds of the surface
receptor expression level of abg2 cells, we loaded only
a fraction of the receptors on the abg2 cells while saturat-
ing the ag2 cells with IgE in an attempt to engage the
same (0.6 mg, Figure 1B, lanes 1 and 2) or smaller (0.4
mg, lanes 3 and 4) number of receptors on abg2 cells as
are present on the ag2 cells (lanes 5 and 6). Cells loaded
with appropriate amounts of anti-DNP IgE were infected
with recombinant vaccinia viruses driving expression of
Lyn kinase. Lyn expression level in each sample was
assessed by anti-Lyn immunoblotting of whole cell ly-
sates (Figure 1B, bottom panel). g chain tyrosine phos-
phorylation was assessed by antiphosphotyrosine
immunoblotting following cell lysis and anti-g immuno-
precipitation (Figure 1B, top panel). As shown pre-
viously, g phosphorylation is easily detected upon re-
ceptor clustering in abg2 cells after expression of Lyn.
However, no detectable g phosphorylation is seen in
ag2 cells after expression of Lyn (Figure 1B, lanes 5 and
6). Even when fewer abg2 receptors are engaged (as in
Figure 1B, lanes 3 and 4), the Lyn-dependent phosphor-
ylation of g in the context of an ag2 receptor (lanes 5
and 6) is far less than that of an abg2 receptor and was
actually not detectable in this experiment (a longer time
exposure was attempted; however, no detectable band
appeared in lane 6). Therefore, the presence of b in abg2
FceRI complexes causes a clear and dramatic enhance-
ment in aggregation-induced Lyn-dependent g tyrosine
phosphorylation.
abg2 Complexes Have Substantially Enhanced Syk
Activation Capacity Compared with ag2 Complexes
To analyze whether the b-mediated enhancement of g
tyrosine phosphorylation has an impact on Syk activa-
tion, we next compared the ability of abg2 and ag2 com-Figure 1. Comparison of ag2 and abg2 Receptors in a Reconstitution
plexes to mediate Syk tyrosine phosphorylation and inSystem
vitro autophosphorylation activity. Expression of Syk(A) FACScan analysis of FceRI expression on abg2, ag2, and agYM2
alone results in no detectable basal and very little or noNIH 3T3 sublines. The cells were stained with FITC-conjugated
clustering-dependent Syk tyrosine phosphorylation inmouse IgE with (dashed lines) or without (solid lines) preincubation
with unlabeled IgE. ag2 cells (Figure 1C, lanes 5 and 6) or in abg2 cells (data
(B) b promotes g tyrosine phosphorylation. Cell lysates from abg2 not shown; see Scharenberg et al., 1995). Coexpression
and ag2 cells were immunoprecipitated with the anti-g antibody, and of Lyn and Syk produces a detectable clustering-depen-
the products were analyzed by Western blotting with the antiphos-
dent tyrosine phosphorylation and activation of Syk inphotyrosine antibody (top panel) then stripped and reprobed with
both ag2- and abg2-expressing cells (Figure 1C, lanesthe anti-g antibody (middle panel). Alternatively, the cell lysates were
2, 4, and 8). Therefore, in both ag2- and abg2-expressingimmunoblotted with anti-Lyn antibody (bottom panel). A fraction of
the total receptors expressed on abg2 cells (3.0 3 105 receptors/ cells, tyrosine phosphorylation and activation of Syk are
cell) were bound to anti-DNP IgE (0.6 fraction, lanes 1 and 2; 0.4 dependent on Lyn and receptor clustering. However,
fraction, lanes 3 and 4). All receptors expressed on ag2 cells (2.1 3 comparison of lanes 2 and 8 by densitometry scanning
105 receptors/cell) were saturated with IgE (lanes 5 and 6). Cells
analysis indicates that the tyrosine phosphorylation ofwere infected with Lyn recombinant virus and triggered (lanes 2,
Syk in abg2 cells is about 20 times that in ag2 cells, while4, and 6) or not (lanes 1, 3, and 5) with the multivalent antigen
Syk autophosphorylation activity in abg2 cells is aboutDNP–HSA.
(C) Syk tyrosine phosphorylation and autophosphorylation activity 8 times that in ag2 cells.
is amplified by b. Lysates were immunoprecipitated with anti-Syk Since there is no detectable g chain tyrosine phos-
antibody, and analyzed by immunoblotting with antiphosphotyro- phorylation in ag2 cells, even though there is a smallsine antibody (top panel), then after stripping, were reprobed with
clustering-dependent Syk activation, we tested whetheranti-Syk antibody (bottom panel). Alternatively, immunorecipitates
the g ITAMs in ag2 cells are essential for Syk activationwere analyzed by in vitro kinase assay (IVK) (middle panel). The
by comparing ag2 and agYM2 cells with similar levels ofexperimental conditions are as in (B) except that the cells were
infected with the indicated combinations of recombinant viruses. receptor expression (Table 1; Figure 1A, bottom panel).
(D) Tyrosine mutation of g ITAMs abolishes Syk tyrosine phosphory- Both ag2 and agYM2 cells were saturated with anti-DNP
lation and autophosphorylation activity. Lysates were analyzed as IgE and infected with Lyn and Syk recombinant vaccinia
in (C). ag2 and agYM2 were saturated with IgE, and infected with Lyn viruses, followed by analysis of Syk tyrosine phosphory-
and Syk recombinant viruses and triggered (lanes 2 and 4) or not
lation and activation. As can be seen, cross-linking of(lanes 1 and 3) with DNP–HSA.
FceRI does not result in tyrosine phosphorylation and
activation of Syk kinase in agYM2 cells (Figure 1D, top
Cell
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and middle panels). Anti-Syk immunoblots of the anti-
Syk immunoprecipitates (Figure 1D, bottom panel) and
anti-Lyn immnunoblots of whole lysates (data not
shown) show that the same amount of Syk was precipi-
tated in each lane, and the same amount of Lyn kinase
was expressed in each sample. This result suggests
that a low level of Lyn-dependent phosphorylation of g
ITAMs, not detectable using our methods, is occuring
in ag2 complexes. The g phosphorylation is accompa-
nied by activation of Syk by ag2 complexes, demonstrat-
ing that the g ITAM is capable of mediating Syk activa-
tion autonomously.
Taken together with the results in Figure 1C, these
data suggest that the presence of b enhances the ability
of g to activate Syk substantially by up-regulating its
tyrosine phosphorylation. If b functioned to activate Syk
directly, the enhanced ability of abg2 FceRI to activate
Syk (relative to ag2 FceRI) could be accounted for by
the presence of the b ITAM in the abg2 complexes only
if one b ITAM were much stronger in directly activating
Syk than two g ITAMs. However, previous data from our
laboratory indicate that the b ITAM has little, if any,
cell activation capability in the context of a single-chain
chimeric receptor (Jouvin et al., 1994). Therefore, b ap-
Figure 2. Both NH2 and COOH Tails of b Are Involved in the En-pears to act through g, suggesting that b functions as hancement of g Phosphorylation
a signal amplifier. (A) FceRI expression on abNTg2 and abCTg2 NIH 3T3 sublines. Cells
were analyzed as in Figure 1A.
(B) Lysates from abg2 and abNTg2 cells were immunoprecipitated
Molecular Analysis of b Amplification with anti-IgE, and analyzed with antiphosphotyrosine immunoblot-
ting (top panel) and then stripped and reprobed with anti-b antibodyof Signaling in a Reconstitution System
(NB) (middle panel) or anti-g antibody (bottom panel). Note that NBImplicit in the concept of b and Lyn working together
reacts with the carboxy-terminal tail of b subunit.as a signal amplifier is the existence of specific b–Lyn
(C) Lysates from abg2 and abCTg2 were treated as in (B), except thatinteractions that mediate the amplification process. The the anti-b antibody (JRK) that reacts with the amino-terminal tail of
following series of experiments using various FceRI mu- b was used in the immunoblot.
tants were performed in order to dissect the regions of Cells were saturated with anti-DNP mouse IgE, and infected with
Lyn virus before being triggered (lanes 2 and 4) or not (lanes 1 andb that are involved in the amplification process. The
3) with antigen and lysed in lysis buffer with 10 mM CHAPS (B) orNIH 3T3 cell lines expressing the various types of FceRI
0.5% Triton X-100 (C).complexes that were used in the following experiments
are listed in Table 1.
Both Cytoplasmic Tails of b Participate
analyzed by antiphosphotyrosine immunoblotting (Fig-in b-Mediated Enhancement
ure 2B, top panel). As can be seen, truncation of theof g Tyrosine Phosphorylation
NH2 tail of b substantially reduces the magnitude ofThe experiment in Figure 1B above suggests that ag2
both antigen-induced b and g tyrosine phosphorylationand abg2 receptors access Lyn for proximal signaling
(Figure 2B, compare lanes 2 and 4). The g phosphoryla-events with very different efficiencies. Since the pres-
tion in the abNTg2 receptors is detectable in a longerence of b enhanced the ability of abg2 receptors to
exposure (data not shown). Anti-b and anti-g immu-induce g tyrosine phosphorylation, our initial investiga-
noblots of the same membrane demonstrate the relativetion focused on how FceRIb might mediate this effect.
amount of b and g subunits of each form of FceRI inSince b has two cytoplasmic tails, we first investigated
each lane (Figure 2B, middle and bottom panels). Thewhether either or both b cytoplasmic tails participated
b NH2 tail truncation mutant destabilized the FceRI com-in the enhanced g tyrosine phosphorylation in abg2 re-
plex (relative to the wild-type abg2 complex) in Tritonceptors. For this purpose, we generated cell lines ex-
X-100 lysates (data not shown). Therefore, this experi-pressing tetrameric FceRI containing either NH2 tail or
ment was performed using 10 mM CHAPS containingCOOH tail truncation mutant forms of b. A fluorescence-
lysis buffer (Kinet et al., 1985). Under these conditions,activated cell sorter (FACS) analysis of the surface ex-
clustered receptors are solubilized less efficiently, re-pression of the abNTg2 and abCTg2 cell lines is shown in
sulting in the decrease in immunoprecipitable b andFigure 2A.
g seen after triggering (Figure 2B, lanes 2 and 4). WeWe first compared antigen-induced g phosphorylation
performed a similar experiment to compare FceRIgin abg2 receptors with that in abNTg2 receptors. Equal
phosphorylation in abg2 receptors with that in abCTg2numbers of cells from the respective cell lines loaded
receptors (Figure 2C). As can be seen, there was sub-with IgE were infected with Lyn recombinant vaccinia
stantially reduced g tyrosine phosphorylation in thevirus for 2 hr. The cells were then triggered with antigen,
lysed, subjected to anti-IgE immunoprecipitation, and abCTg2 cells (Figure 2C, compare lanes 2 and 4). Again,
The FceRIb Amplifier
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Figure 4. Direct Comparison of g Tyrosine Phosphorylation in abg2,
abNTg2, and abCTg2 Cells
(A) Anti-IgE immunoprecipitation followed by antiphosphotyrosine
immunoblotting of lysates (top panel). The same membrane was
stripped and reprobed with anti-g immunoblotting to verify the
amount of g chain present (middle panel). Lyn expression in each cell
type was assessed by anti-Lyn immunoblotting of lysates (bottom
panel).
(B) The intensity of each band in top and middle panels of (A) was
quantified by densitometry scanning. The ratio of g tyrosine phos-
phorylation to the amount of g was calculated and plotted for each
cell type.
The experiment was similar to that in Figures 2B and 2C. abg2,Figure 3. b ITAM Tyrosine Phosphorylation Regulates g ITAM Tyro-
abNTg2, and abCTg2 cells were infected with Lyn recombinant virus,sine Phosphorylation
and lysed in 10 mM CHAPS lysis buffer.(A) FceRI expression on abgYM2, abYMg2, and abYMgYM2 NIH 3T3 sub-
lines. Cells were analyzed as in Figure 1A.
(B) Lysates were immunoprecipitated with anti-IgE, and analyzed
with antiphosphotyrosine immunoblotting (top panel) and then
described above (Figures 3B and 3C). As expected, anti-stripped and reprobed with anti-b antibody (JRK) (bottom panel).
IgE immunoprecipitation of lysates followed by immu-(C) Equal amount of Lyn expression in each cell type was confirmed
noblotting with antiphosphotyrosine antibody shows noby anti-Lyn immunoblotting of whole cell lysates.
Cells were saturated with IgE, infected with Lyn recombinant virus, tyrosine phosphorylation of mutated subunits (Figure
and triggered (lanes 2, 4, 6, and 8 ) or not (lanes 1, 3, 5, and 7 ) with 3B, upper panel). The b chain in abgYM2 cells isphosphor-
DNP–HSA. ylated by Lyn as efficently as that in abg2 cells after
triggering (Figure 3B, compare lanes 2 and 4), demon-
the g phosphorylation was detectable in abCTg2 recep- strating that g does not regulate b tyrosine phosphoryla-
tors with a very long exposure (data not shown). These tion. Substantially reduced g chain tyrosine phosphory-
results demonstrate that the NH2 tail has some involve- lation is observed in abYMg2 cells (Figure 3B, lanes 5 and
ment in generating phosphorylation of the b ITAM and 6, top panel). Together, these two results provide strong
that both the NH2 and COOH tails participate in b-medi- support for the idea that the phosphorylated b ITAM is
ated enhancement of g tyrosine phosphorylation in abg2 critical for b-mediated enhancement of Lyn-dependent
receptors. g ITAM phosphorylation.
b ITAM Tyrosine Phosphorylation Regulates The above experiment demonstrates that Lyn-depen-
g Tyrosine Phosphorylation dent g tyrosine phosphorylation is mediated largely, if
The effect of the b NH2 tail truncation on b ITAM phos- not entirely, through a mechanism involving an interac-
phorylation togetherwith previous results from our labo- tion between Lyn and the phosphorylated b ITAM, con-
ratory that implicate the b ITAM in the generation of sistent with the sequential interaction mechanism pro-
g phosphorylation suggested that the b amplification posed above. As a further test of this mechanism, we
mechanismmight be the result of sequential interactions
compared antigen-induced Lyn-dependent g tyrosine
between Lyn and b (Jouvin et al., 1994). In such a mecha-
phosphorylation between abg2, abNTg2, and abCTg2 re-nism,a basal interaction between Lyn and b (presumably
ceptors. Since there is still detectable b ITAM phosphor-somehow stabilized by the NH2 tail) would be responsi- ylation in abNTg2 receptors, these receptors would beble for the phosphorylation of the b ITAM, with b ITAM
expected to produce a higher level of FceRIg tyrosinephosphorylation serving to recruit or activate Lyn to
phosphorylation than abCTg2 receptors if the sequentialgenerate g tyrosine phosphorylation. Therefore, to ana-
interaction mechanism as conceived above was op-lyze further the mechanism through which b was acting
erating. Because of the varying receptor stabilities into enhance Lyn-dependent g tyrosine phosphorylation,
Triton X-100 cell lysates, this experiment was performedwe produced transfectants bearing receptors with g
using the 10 mM CHAPS lysis buffer for cell lysis, fol-ITAM tyrosine mutations (abgYM2 cells), b ITAM mutations
lowed by anti-IgE immunoprecipitation and antiphos-(abYMg2), or both types of mutations (abYMgYM2 cells) (see
photyrosine blotting (Figure 4A, top panel). Note that aTable 1). The FACS analysis of these cell lines is shown
very long exposure of the membrane was necessary toin Figure 3A.
visualize the g phosphorylation that is induced in abNTg2The various ITAM mutant receptors were compared
and abCTg2 receptors. The same membrane was strippedwith abg2 receptors in terms of antigen-induced g tyro-
sine phosphorylation in experiments analogous to those and reprobed with anti-g (Figure 4A, middle panel), and
Cell
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the antiphosphotyrosine and anti-g bands were quanti- ITAM to Syk activation, we analyzed antigen-induced
Syk activation occurring in the cell lines expressing thefied by densitometry. The ratio of g tyrosine phosphory-
lation to the amount of g subunit was then computed various FceRI ITAM mutants. Tyrosine phosphorylation
and activationof Syk uponreceptor triggering was minorfor each receptor (Figure 4B). As can be seen, this ratio is
reproducibly highest in abg2 cells, intermediate in abNTg2 in the abgYM2 and abYMg2 cells and completely abolished
in abYMgYM2 cells (Figure 5B, compare lane 2 with lanescells, and lowest in abCTg2 cells. This result suggests
that the b NH2 tail truncation reduces Lyn-dependent b 4, 6, and 8). In fact, even though b in abgYM2 cells is
tyrosine-phosphorylated to the same degree as in wild-ITAM phosphorylation (see Figure 2), which then sec-
ondarily results in a reduction in g ITAM phosphoryla- type receptor (see Figure 3B, compare lanes 2 and 4),
these FceRI complexes induced virtually no Syk activa-tion, consistent with the dramatic effect of mutation of
b ITAM tyrosines seen in Figure 3. This result strongly tion and phosphorylation. Furthermore, Syk activation
in response to abYMg2 engagement (where there is nosupports the idea that the b amplification mechanism
involves a sequence of interactions between Lyn and detectable g chain phosphorylation) is greater than that
which occurs in abgYM2 cells, despite the fact that theyb: an initial basal interaction that is required for b ITAM
phosphorylation, followed by an interaction between have full b chain phosphorylation (Figure 5B, compare
lanes 4 and 6). Therefore, the b ITAM has very little orLyn and the b ITAM that is directly responsible for en-
hancement of g phosphorylation. no autonomous cell activation capability when present
in the context of a tetrameric receptor. Quantitation ofEffect of b and g ITAM Mutations
on Syk Activation the intensity of tyrosine-phosphorylated Syk in a typical
experiment by densitometry scanning reveals that tyro-Our initial comparison of ag2 and abg2 receptors sug-
gested that b functions as an amplifier whose purpose sine phosphorylation of Syk in abg2 cells is at least 20
times higher than that in abgYM2 cells and 7 times higheris to regulate the level of g dimer phosphorylation, and
so the strength of Syk activation mediated through the than that in abYMg2 cells. Taken together, these results
demonstrate that the Syk activation signal mediatedg dimer, but with little or no direct contribution to Syk
activation. The molecular analysis of the mechanism through FceRI is almost entirely transduced through the
g dimer, and that the addition of the autonomous activi-through which b enhances g tyrosine phosphorylation
established that phosphorylation of the b ITAM is re- ties of b (Figure 5B, lane 4) and g (lane 6) cannot account
for the activity of the tetrameric complex (lane 2). Theyquired. Since activation of the Syk tyrosine kinase is
known to lie directly downstream of b/g tyrosine phos- therefore formally demonstrate that b amplifies the Syk
activation signal transduced through g with a gain ofphorylation, Syk activation provides an ideal surrogate
marker for testing the degree of compartmentalization z7–8 (based on these data and Syk activation in the
abg2/ag2 comparison in Figure 1C).of signaling function (to g) and signal amplifier function
(to b). That is, if Syk activation were perfectly compart-
mentalized to the g dimer, the various receptor muta-
Comparison of ag2 and abg2 Receptor Signalingtions used above for the analysis of the b amplification
Characteristics in a Hematopoieticmechanism should have the following predictable ef-
Monocytic Cell Linefects on Syk activation: first, mutations of b that affect
The advantages of the reconstitutionsystem used aboveg tyrosine phosphorylation should affect the strength of
are to provide unlimited control over the structures ofSyk activation in proportion to their effect on g tyrosine
the receptor subunits and Lyn and Syk tyrosine kinases,phosphorylation; and second, mutations of the g ITAM
and, therefore, to permit reconstitution and detailed mo-tyrosines should eliminate the ability of the receptor to
lecular analysis of interactions between known mole-activate Syk, since this would result in inactivation of
cules. However, there is the possibility that the recon-the receptor module responsible for sending the cell
stitution system might overlook potentially majoractivation signal.
influences of other hematopoietic specific molecules,We first compared the Syk tyrosine phosphorylation
such as hematopietic specific phosphatases. In addi-and activation in the abNTg2 and abCTg2 cell lines with
tion, this system lacks a downstream readout, whichthose that occur in the abg2 cell line. All three cell lines
could be used to determine whether b-amplified Sykwere coinfected with Lyn and Syk recombinant vaccinia
activation would translate into physiologically relevantvirus, followed by anti-Syk immunoprecipitation and im-
enhancements of other cell activation events. Becausemunoblotting with antiphosphotyrosine and in vitro ki-
ag2 and abg2 receptors are known to exist naturally innase assay (Figure 5A, top and middle panels). As ex-
humans (Maurer et al., 1994), we were particularly inter-pected, no basal Syk tyrosine phosphorylation was
ested in comparing their signaling characteristics in apresent (Figure 5A, lanes 1, 3, and 5). There was cluster-
system that was entirely human. Therefore, we choseing-dependent Syk tyrosine phosphorylation and auto-
to use the FceRI negative human monocytic cell linephosphorylation activity in all cell lines, but at reduced
U937 to generatesublines expressing human ag2 or abg2levels in the FceRI complexes that contain either b trun-
complexes for more extensive functional comparisons.cation mutant as compared with FceRI complexes that
Two clones of each type were chosen (ag-1 and ag-10,contain a wild-type b chain (Figure 5A, lanes 2, 4, and 6).
abg-2 and abg-8) for further analysis in order to ruleThe magnitude of Syk tyrosine phosphorylation roughly
out the possibility that clonal differences in triggeringparallels the level of g phosphorylation seen in Figure
sensitivity or small differences in receptor expression4B (Figure 5C), consistent with the idea that g is the
between the cell lines could cause apparent differencesprimary route for cell activation signals.
To analyze the relative contributions of each FceRI in receptor signaling characteristics. A FACS analysis
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Figure 5. Effect of Cytoplasmic Tail Trunca-
tions and ITAM Mutations of b on Syk Acti-
vation
(A) Truncation of either NH2 or COOH tail of
b results in reduction of tyrosine phosphory-
lationandautophosphorylation activityof Syk.
Lysates of abg2, abNTg2, and abCTg2 cells were
immunoprecipitated with anti-Syk antibody,
and the immunoprecipitates were analyzed
by immunoblotting with antiphosphotyrosine
antibody to show the phosphorylation state
of Syk (top panel). Alternatively, immunopre-
cipitates were analyzed by in vitro auto-
phosphorylation assay and autoradiography
(middle panel). Same amount of Syk in anti-
Syk immunoprecipitation was confirmed by
anti-Syk immunoblotting (bottom panel).
(B) b ITAM mutation greatly decreases g-mediated activation of Syk. abg2, abgYM2, abYMg2, and abYMgYM2 cells were analyzed as in (A).
(C) The relative intensity of tyrosine phosphorylation of Syk of abg2, abNTg2, and abCTg2 cells was quantified by densitometric analysis of the
top panel of (A).
Cells were loaded with IgE, infected with both Lyn and Syk recombinant viruses, triggered (plus) or not (minus) with antigen, and lysed in
0.5% Triton X-100 lysis buffer.
of their human FceRI surface expression is shown in and abg-8 cells was compared with that in ag-1 or ag-10
cells (Figure 6B). Antiphosphotyrosine immunoblottingFigure 6A, and the mean receptor numbers were as-
sessed by IgE binding assay (2.5 3 104 receptors/cell following anti-g immunoprecipitation demonstrated that
tyrosine phosphorylion is only detected in abg2 cellsfor ag-1 and abg-8, 2.3 3 104 for ag-10, and 4.2 3 104
for abg-2). (Figure 6B, top panel, lanes 6 and 8). A parallel experi-
ment utilizing an antiphosphotyrosine immunoprecipita-g Tyrosine Phosphorylation and Syk Activation
after Engagement of abg2 or ag2 Receptors tion from identical lysates was also performed and ana-
lyzed by anti-g immunoblotting (Figure 6B, bottomin U937 Cells Exactly Parallel the Results
in the Reconstituted System panel). After a long exposure, there were faint bands of
tyrosine-phosphorylated g subunit showing up in lanesWe first compared these clones in terms of g subunit
tyrosine phosphorylation and Syk tyrosine phosphoryla- 2 and 4 in the bottom pannel, confirming that there is
a small amount of tyrosine-phosphorylated g subunittion/activation. Tyrosine phosphorylation of g in abg-2
Figure 6. Comparison of ag2 andabg2 Human
FceRI-Mediated Signaling in U937 Cells
(A) FACScan analysis of U937 cells express-
ing human ag2 and abg2 FceRI complexes.
Transfected U937 clones were labeled with
biotinylated human IgE followed by PE-con-
jugated streptavidin with (dashed lines) or
without (solid lines) preincubation with unla-
beled anti-human a subunit antibody (15–1).
(B) and (C) b chain amplifies receptor (B) and
Syk (C) phosphorylation in U937 expressing
human FceRI. Cells were loaded overnight
with anti-DNP mouse IgE, which also binds to
human FceRI, and stimulated with DNP–HSA
(lanes 2, 4, 6, and 8) or not (lanes 1, 3, 5, and
7) and lysed.
(B) Lysates were immunoprecipitated with
the anti-g subunit antibody, and analyzed by
antiphosphotyrosine (top panel) and anti-g
immunoblotting (middle panel). Identical ly-
sates were also subjected to antiphosphoty-
rosine immunoprecipitation followed by anti-
g immunoblotting (bottom panel; this blot was
heavily overexposed).
(C) Lysates were also immunoprecipitated
with the antihuman Syk antibody and further
analyzed by immunoblotting with the anti-
phosphotyrosine antibody (top panel) or with
anti-human Syk antibody (bottom panel). Al-
ternatively, immunoprecipitates were ana-
lyzed by in vitro kinase assay (middle panel).
(D) b amplifies calcium mobilization in human FceRI-expressing U937 cells. Calcium mobilization in ag2- and abg2-expressing U937 cells was
assessed by fluorescence in a spectrofluorimeter using the Fura 2 indicator. Cells (2.5 3 106/ml) were sensitized with 5 mg/ml biotinylated
human IgE for 10 min and stimulated with 25 mg/ml steptavidin at time 0.
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generated upon triggering in ag2 cells. Identical lysates complexes that contain b is likely to be an important
determinant of the amplitude of an IgE/FceRI-mediatedwere analyzed by anti-Syk immunoprecipitation fol-
lowedby antiphosphotyrosine immunoblotting or in vitro immunologic response.
In addition to demonstrating the function of b as akinase assay (Figure 6C). The abilities of these clones
to initiate tyrosine phosphorylation/activation of Syk signal amplifier, our results provide a rough picture of
the mechanism through which its signal amplificationcorrespond to the level of g tyrosine phosphorylation.
Remarkably, the correlation between g tyrosine phos- effect is generated. While we cannot exclude unpredict-
able effects on receptor tertiary or quaternary structure,phorylation and Syk tyrosine phosphorylation is identi-
cal to that seen in the fibroblast reconstitution system, the effects of the NH2 and COOH cytoplasmic tail trunca-
tions suggest that b amplification is the result of a se-with tyrosine phosphorylation of Syk in abg-8 cells typi-
cally about 20 times greater than that in ag-1 cells, and quence of interactions between Lyn and b: Lyn first
interacts with b at or near the NH2 tail to induce b ITAMthe autophosphorylation activity of Syk typically about
5 times greater (as assessed by densitometry scanning). phosphorylation, then directly interacts with the phos-
phorylated b ITAM to induce g tyrosine phosphorylation.These results, therefore, confirm in a completely sepa-
rate system that b functions as a signal amplifier, and, Since the b NH2 tail has numerous proline residues (al-
though no consensus SH3 binding site), it was reason-remarkably, give a nearly identical value for the gain
provided by the presence of b (5 here as compared with able to consider that the Lyn SH3 domain might partici-
pate in the initial Lyn–b interaction (Ren et al., 1993).7–8 in the reconstitution system).
b Amplifies Calcium Mobilization However, deletions of both the Lyn unique region (amino
acids 20–66) and SH3 (amino acids 67–117) do not affectU937 cells also provide the opportunity to demonstrate
whether amplified FceRI-mediated Syk activation trans- either b or g tyrosine phosphorylation (S. L., A. M. S.,
and J.-P. K., unpublished data), suggesting that the firstlates into enhancement of a downstream effector sys-
tem, the calcium flux. FceRI-mediated calcium mobiliza- interaction is probably mediated through the first 20
amino acids of Lyn, which includes a consensus myristi-tion was compared in the various U937 transfectants,
using the calcium-sensitive dye Fura 2 and spectrofluor- lation signal and which is present in both of these dele-
tion mutants. Consistent with the functional relevanceimetry (Figure 6D). In this experiment, cells were incu-
bated with biotinylated monoclonal human IgE for 10 of this portion of Lyn are previous in vitro binding studies
that implicate the first 10 amino acids of Fyn in mediatingmin in the bulk spectrofluorimeter cuvette, followed by
direct addition of avidin for cross-linking purposes. This its association with a chimera containing the cyto-
plasmic tail of the T cell receptor z subunit (Timsonled to a reproducible increase of cytosolic-free calcium
for all four clones. However, the fluxes initiated by the Gauen et al., 1992) and that implicate a similar region
of Lyn and Fyn in their binding to the B cell receptorreceptors on ag-1 and ag-10 cells were substantially
delayed and of much smaller absolute magnitude than Iga cytoplasmic tail (Pleiman et al., 1994). The second
step of the proposed sequence clearly involves modula-those initiated by the receptors on abg-2 and abg-8
cells. The increment of the initial cytosolic calcium rise tion of the interaction between Lyn and b by phosphory-
lation of the b ITAM, resulting in the observed enhance-inside abg-8 cells was typically about five times more
than that in ag-1 cells. Therefore, b signal amplification ment of the ability of Lyn to phosphorylate g. This step
is likely to be due to an interaction between the Lyn SH2extends to calcium mobilization, and probably to other
downstream events as well. domain and the phosphorylated b ITAM, resulting in the
recruitment to or activation of Lyn, or both, by receptor
complexes with phosphorylated b (Kihara and Siragan-
Discussion ian, 1994; Pleiman et al., 1994). A more extensive muta-
tional analysis of the sequences required for both the
Conceptually, an amplifier is a mechanism that itself initial Lyn–b interactions and Lyn–phosphorylated b
does not participate in the generation of the specific ITAM–dependent interactions is currently in progress.
characteristics of a signal, but instead proportionally One aspect of our data has wider implications for
increases the amplitude of one or more of the character- antigen receptor signaling: the functional compartmen-
istics that make up the signal. The multiple of thepropor- talization of amplification and activation between b and
tional increase (relative to the initial input signal strength) g. The b ITAM had essentially no Syk activation capabil-
is termed the “gain” of the amplifier. The experimental ity in the context of an abg2 FceRI, even when fully
results described above provide a clear demonstration phosphorylated, but had dramatic effects on g phos-
that b meets the conceptual definition of an amplifier in phorylation. In contrast, the g ITAM had Syk activation
terms of its effects on Syk activation/calcium mobiliza- capabilities even when its phosphorylation level was
tion: it has little or no autonomous ability to generate a extremely low, as in the context of abYMg2 or ag2 recep-
signal in response to receptor cross-linking but provides tors, but had no apparent ability to regulate b ITAM
a proportional increase in the strength of the signal that phosphorylation. Therefore, while ITAMs are currently
is mediated through the g dimer. In addition, these ex- widely conceived of as parallel independent signal-
periments provide independent estimates that place the transducing modules (Weiss, 1993; Weiss and Littman,
b gain at 5–7 in terms of relative induction of Syk auto- 1994), this is clearly not the case for FceRI. Instead, b
phosphorylation activity and calcium mobilization. Since functions to amplify signals that are transduced through
Syk activation and the calcium flux are upstream of g. Furthermore, the amplifier function of b is in contrast
most, if not all, FceRI-dependent downstream events with the function of autonomous coreceptors, such as
CD4 and CD8 in T lymphocytes and CD19 and CD21 inthat occur in mast cells, the relative proportion of FceRI
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B lymphocytes, whose cell activation signals are closely development of atopy suggests that individuals carrying
these variants have some aberration of their IgE/FceRI-coordinated with that of an antigen receptor (Fearon
and Carter, 1995; Weiss and Littman, 1994). First, b mediated immunologic responses. The amplification
function of b demonstrated here has the obvious impli-has little or no extracellular portion and can only be
expressed as part of an FceRI signaling complex, while cation that the responses of these individuals might be
potentiated by the variant of b that they carry. Suchknown coreceptors are expressed independently of
their cognate antigen receptor and have extracellular potentiated responses could occur as the direct result
of increases in the intrinsic b amplifier gain associatedstructures that function to allow their engagement by
external ligands. Second, and more importantly, b can- with some b variants. Alternatively, since both abg2 and
ag2 receptors exist in humans, a particular b gene poly-not signal in the absence of an intact g activation mod-
ule, while coreceptors are able to transduce signals in- morphism might increase the proportion of abg2 to ag2
receptors, thereby increasing the average gain of thedependently of the engagement of their cognate antigen
receptor. The amplifier function demonstrated for b is, total FceRI population of one individual, and so the over-
all FceRI-mediated signal strength. The concept of btherefore, at present unique among antigen receptor
subunits or receptor-associated molecules. Detailed as a signal amplifier therefore provides an important
foundation for future investigations of how b polymor-analysis of other multisubunit antigen receptors may
reveal previously unappreciated cooperative functional phisms affect FceRI-mediated signaling and in vivo
FceRI-mediated responses.interactions between receptor subunits. Such coopera-
tive interactions would provide further evolutionary ra-
Experimental Procedurestionale for the complex and varied multisubunit receptor
structures found throughout the antigen receptor super-
Cell Culturefamily.
The abg2 cells were maintained in DMEM (Biofluids, Rockville, MD)Two previous studies have examined the functional with 10% calf serum (Biofluids) and 300 mg/ml of hygromycin (Calbi-
role of the b chain in FceRI signaling. Previous work by ochem, La Jolla, CA) and 500 mg/ml of G418 (GIBCO BRL, Baltimore,
Alber et al. (1991) found that ag2 receptors were able to MD). All the other NIH 3T3 transfected cell lines were maintained in
the same medium without neomycin. The two U937 transfected cellactivate P815 mouse mast cells normally in terms of
lines were maintained in RPMI 1640 (Biofluids) with 20% fetal bovinecalcium mobilization, but did not examine other aspects
serum (Biofluids) and 1 mg/ml of G418.of the FceRI-mediated signaling. This study was limited
in terms of its ability to compare the relative magnitude Expression Vectors
of calcium signals elicited through ag2 or abg2 receptors, The human a subunit and mutated form of rat b cDNA (bYM, tyrosines
because abg2 receptors were apparently engaged using at positions 218, 224, and 228 within b ITAM were changed to
phenylalanines) of FceRI were subclonedinto pCDL-SRa 296 (Jouvinan anti-rat a monoclonal antibody cross-linking stimulus
et al., 1994). The rat a and g subunits of FceRI were subcloned into(the BC4 monoclonal antibody), while ag2 receptorswere
pSHSX (Jouvin et al., 1994). Human b and g subunit, rat b subunitapparently engaged using IgE/antigen. In addition, our
cDNA, andthe mutated form of rat g cDNA(gYM, tyrosines at positionsprevious work in P815 cells, which compared abg2 re- 65 and 76 within the g ITAM were changed to phenylalanines) (Paolini
ceptors with abYMg2 receptors, did not detectdifferences et al., 1995) were subcloned into pBJ1neo (Jouvin et al., 1994). The
in the calcium flux amplitudes mediated by these recep- truncated forms of rat b (bNT, the first 57 amino acids of NH2-terminal
cytoplasmic domain were deleted; bCT, the last 38 amino acids oftors (Jouvin et al., 1994). However, this study also used
COOH-terminal cytoplasmic domain were deleted) have been de-the BC4 antibody as the stimulus for the calcium mea-
scribed (Varin-Blank andMetzger, 1990). bNT and bCT were subclonedsurement. Our past experience indicates that BC4 pro-
into pCDL-SRa 296.
vides a very strong cross-linking stimulus (J.-P. K.,
unpublished data), and its use may have obscured po- Antibodies
tentially real differences in signaling capability. Of note is Monoclonal antiphosphotyrosine antibody (4G10) was purchased
from Upstate Biotechnology, Incorporated (Lake Placid, NY). PE–that other experiments in this same study demonstrated
streptavidin were from PharMingen (San Diego, CA).The monoclonaldifferences in the tyrosine phosphorylation patterns in-
anti-DNP IgE used in culturesupernatant form, rabbit antimouse IgE,duced by IgE/antigen engagement of abg2 and abYMg2 antirat b subunit monoclonal antibody (JRK), rabbit anti-g subunit
receptors, which, in retrospect, are consistent with our antibody, and monoclonal antihuman a subunit antibody (15–1) were
current results. Finally, the stimulation conditions used prepared as described (Jouvin et al., 1994). Rabbit antiporcine Syk
in the calcium measurements above involved loading and antimurine Lyn were described previously (Scharenberg et al.,
1995). The antihuman Syk antibody 996 was raised against a syn-the U937 cells with IgE followed by addition of the cross-
thetic peptide representing amino acids 150–159 of human Syk se-linking stimulus 10 min later. This stimulation protocol
quence (Jouvin et al., 1994). Monoclonal antirat b antibody (NB) waswas used because it was thought to be more consistent
from Dr. D. Holowka, and chimeric human IgE was from Dr. Z. Eshharwith what might occur invivo when an individual encoun-
(Schwarzbaum et al., 1989).
ters an environmental antigen. It may be that this proto-
col provides a submaximal stimulus because the IgE Recombinant Vaccinia Virus Construction
does not all become cell bound in 10 min, resulting Recombinant vaccinia virus expressing murine LynA kinase, porcine
Syk kinase, and virus with the empty pSC-65 vaccinia recombinantin some unbound IgE that is available to bind to and
plasmid were constructed as described (Scharenberg et al., 1995).inactivate some portion of the cross-linking stimulus
before it encounters cell-bound IgE. Such a submaximal
Construction of NIH 3T3 and U937 Sublines
stimulus may have allowed our experimental protocol The generation of abg2 cells (also named 3T3E) has been previously
to emphasize the difference between the amplitude of described (Scharenberg et al., 1995). Construction of other NIH 3T3
signals transduced by ag2 and abg2 receptors. sublines expressing FceRI variants was similar. In brief, cells were
coelectroporated (270 V, 960 mF) with appropriate constructs (seeThe existenceof b polymorphisms associated with the
Cell
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Table 1). Resistant clones were selected with 0.3 mg/ml of hygro- Acknowledgments
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